This video demonstrates a totally endoscopic robotic sleeve lobectomy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Thoracic
April 24, 2018
This video demonstrates a robotic-assisted left upper lobectomy for lung cancer in a patient with hilar node metastasis.
April 24, 2018
Stiles and colleagues retrospectively analyzed prospectively-collected data on approximately 3,200 surgical lung cancer patients, finding that more than one fifth of these patients are never-smokers. Compared to patients with a history of smoking, never-smokers were more likely to be younger, female, and to suffer from adenocarcinoma.
April 23, 2018
This video illustrates a four-arm robotic XI video-assisted left pneumonectomy for a large centrally-based carcinoid tumor.
April 19, 2018
This video reviews the technical details of a robotic left upper lobe posterior segmentectomy, using indocyanine green and navigational bronchoscopy.
April 18, 2018
The authors present the minimally invasive management of a proximal left lower lobe carcinoid with endobronchial extension.
April 18, 2018
Dr David Rice discusses CTSNet's first Thoracic Guest Editor Series, which highlights the importance of the robot for minimally invasive approaches to general thoracic surgery.
April 16, 2018
This video demonstrates a VATS resection of a congenital lobar emphysema in a young woman with spontaneous pneumothorax, and the author discusses the presence of osseous metaplasia of the lung.
April 13, 2018
The authors demonstrate that mediastinoscopy at the time of either open or VATS lobectomy is independently associated with an increased risk of postoperative pulmonary complications (OR 1.46 and 1.53, respectively).
April 13, 2018
This retrospective analysis of salvage esophagectomy after definitive chemoradiotherapy in 308 patients identified increased mortality and morbidity associated with squamous histology and radiation dose >55 Gy. Survival at three years was 34%.